$42,106,159
to LEIDOS BIOMEDICAL RESEARCH INC
CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Modification to the 2020 NIH contract funds molecular characterization of childhood cancer trial specimens for precision treatment development.
Childhood cancer treatments informed by comprehensive molecular data could improve outcomes and support personalized medicine research.
This contract supports biomedical research infrastructure that informs pharmaceutical development and diagnostic tool creation for pediatric oncology.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-12. Cost: $0.012393.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N91020F00021_7529_75N91019D00024_7529.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.